Summary
- Current Price
- As of today, AMRX price is $18.15, up +5.10% on
- Current Price All-Time High
- AMRX price is currently -25.86% below its historical high of $24.48 set on
- Market Cap
- AMRX current market cap is $6B, up +114.37% over the past 365 days
- PE Ratio
- AMRX current PE ratio is 37.88
- Revenue
- AMRX current annual revenue is $3.02B, up +8.05% year-over-year
- Next Earnings
- The next earnings release for AMRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Amneal Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AMRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amneal.com |
| Employees | 8,300 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $18.15 | |
| Price, 1D Change | +5.10% | |
| $6B | ||
| - | ||
| 37.88 | ||
| 0.63 | ||
| $3.02B | ||
| Revenue, 1Y Change | +8.05% | |
| $0.22 | ||
| EPS, 1Y Change | +158.63% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.22 | ||
| EPS Estimate | $1.01 | N/A |
| EPS Est. Change | +353.20% | N/A |
| $3.02B | ||
| Revenue Estimate | $3.14B | N/A |
| Revenue Est. Change | +4.13% | N/A |
| Current Price | $18.15 | |
| Price Target | $21.00 | - |
| Price Tgt. Change | +15.70% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.61 | -$0.38 | -161.78% | |
| $0.80 | $0.22 | -72.28% | |
| $1.01 | N/A | +353.20% | |
| $1.18 | N/A | +433.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.77B | $2.79B | +0.81% | |
| $3.01B | $3.02B | +0.23% | |
| $3.14B | N/A | +4.13% | |
| $3.39B | N/A | +12.22% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $18.15 | |
| $13.87 | ||
| $17.12 | ||
| $14.03 | ||
| $16.94 | ||
| $0.19 | ||
| 0.63 | ||
| $0.70 | ||
| 54.58 | ||
| 47.16% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $3.02B | ||
| $0.22 | ||
| $0.00 | ||
| 37.63% | ||
| $423.09M | ||
| 14.02% | ||
| $127.93M | ||
| 4.24% | ||
| $646.66M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -37.98 | ||
| 2.17 | ||
| 1.48 | ||
| - | ||
| 6 | ||
| 1.99 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 37.88 | ||
| 2.03 | ||
| 191.42 | ||
| 13.37 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$70.79M | ||
| $310.87M | ||
| $3.68B | ||
| $1.91B | ||
| $3.67B | ||
| $881.63M | ||
| $2.69B | ||
| $21.58M | ||
| $254.67M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $2.95B | ||
| $713.00M | ||
| $1.88B | ||
| $526.83M | ||
| $223.57M | ||
| $0.00 | ||
| $11.28M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $339.99M | ||
| -$112.26M | ||
| -$31.53M | ||
| $114.36M | ||
| $225.64M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| UBS | → | |
| Barclays | → | |
| UBS | ||
| Truist Securities | → | |
| Barclays | ||
| Piper Sandler | → | |
| JP Morgan | → | |
| Barclays | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with AMRX
FAQ
- What is the ticker symbol for Amneal Pharmaceuticals, Inc.?
- The ticker symbol for Amneal Pharmaceuticals, Inc. is NASDAQ:AMRX
- Does Amneal Pharmaceuticals, Inc. pay dividends?
- No, Amneal Pharmaceuticals, Inc. does not pay dividends
- What sector is Amneal Pharmaceuticals, Inc. in?
- Amneal Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Amneal Pharmaceuticals, Inc. in?
- Amneal Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Amneal Pharmaceuticals, Inc. based in?
- Amneal Pharmaceuticals, Inc. is headquartered in United States
- When did Amneal Pharmaceuticals, Inc. go public?
- Amneal Pharmaceuticals, Inc. initial public offering (IPO) was on May 7, 2018
- Is Amneal Pharmaceuticals, Inc. in the S&P 500?
- No, Amneal Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Amneal Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Amneal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Amneal Pharmaceuticals, Inc. in the Dow Jones?
- No, Amneal Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Amneal Pharmaceuticals, Inc. last earnings report?
- Amneal Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
- When does Amneal Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Amneal Pharmaceuticals, Inc. is October 29, 2026
Data Sources & References
- AMRX Official Website www.amneal.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312826000011/0001723128-26-000011-index.htm
- AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
- AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx